GGrantIndex
← Leaderboards

Kay Huebner

Thomas Jefferson University

$4,927,479
Attributed
$5,944,152
Total exposure
7
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY200621
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$11,519,867 · 8

By mechanism

P01$6,029,612 · 2
R01$2,992,249 · 3
U01$2,262,746 · 1
R25$123,834 · 1
R03$111,426 · 1

Top collaborators

Most similar at Thomas Jefferson University

Same institution · by research overlap

Others in their field

Top investigators on “Cell Line

Research focus

Cell LineDna DamageProteinsMalignant NeoplasmsTumorResponseBaseBreast Cancer CellCancer Cell LineIn VitroCellsMutantTissuesApoptosisTumor Suppressor ProteinsFhit GeneSignal PathwayLesionDefectLinkDna Damage CheckpointErbb2 GeneChromosome Fragile SitesInfection

Grant awards (33)

Ohio State University Discovery PREP for Biomedical Research$123,834
R25 · FY2021 · GM
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy$394,511
U01 · FY2014 · CA · contact PI
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy$411,074
U01 · FY2013 · CA · contact PI
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes$150,175
R01 · FY2013 · CA · contact PI
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy$443,720
U01 · FY2012 · CA · contact PI
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes$159,760
R01 · FY2012 · CA · contact PI
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy$465,130
U01 · FY2011 · CA · contact PI
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes$159,760
R01 · FY2011 · CA · contact PI
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy$548,311
U01 · FY2010 · CA · contact PI
Fhit modulation of cell cycle progression and DNA damage response$319,166
R01 · FY2010 · CA · contact PI
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes$164,803
R01 · FY2010 · CA · contact PI
Fhit modulation of cell cycle progression and DNA damage response$315,942
R01 · FY2009 · CA · contact PI
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes$177,099
R01 · FY2009 · CA · contact PI
Fhit modulation of cell cycle progression and DNA damage response$309,774
R01 · FY2008 · CA · contact PI
Wwox as a Critical Signal Mediator in Breast Cancer$146,205
R01 · FY2008 · CA · contact PI
Fhit modulation of cell cycle progression and DNA damage response$315,000
R01 · FY2007 · CA · contact PI
Wwox as a Critical Signal Mediator in Breast Cancer$146,515
R01 · FY2007 · CA · contact PI
Wwox as a Critical Signal Mediator in Breast Cancer$164,029
R01 · FY2006 · CA · contact PI
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS$906,332
P01 · FY2004 · CA
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS$278,873
P01 · FY2004 · CA
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS$1,150,740
P01 · FY2003 · CA
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS$1,120,885
P01 · FY2002 · CA
ROLE OF THE TCL-5 GENE IN ACUTE T CELL LEUKEMIA AND MELANOMA$197,196
R01 · FY2002 · CA
Fhit Function in Human Cancer$151,299
P01 · FY2002 · CA
NOVEL FAMILIAL CLEAR CELL RENAL CARCINOMA LOCUS$37,142
R03 · FY2002 · TW
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS$1,087,477
P01 · FY2001 · CA
ROLE OF THE TCL-5 GENE IN ACUTE T CELL LEUKEMIA AND MELANOMA$197,196
R01 · FY2001 · CA
Fhit Function in Human Cancer$151,299
P01 · FY2001 · CA
NOVEL FAMILIAL CLEAR CELL RENAL CARCINOMA LOCUS$37,142
R03 · FY2001 · TW
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS$1,031,408
P01 · FY2000 · CA
Fhit Function in Human Cancer$151,299
P01 · FY2000 · CA
ROLE OF THE TCL-5 GENE IN ACUTE T CELL LEUKEMIA AND MELANOMA$69,629
R01 · FY2000 · CA
NOVEL FAMILIAL CLEAR CELL RENAL CARCINOMA LOCUS$37,142
R03 · FY2000 · TW